PDCD1 and Miyoshi myopathy: The addition of anti-PD-1 antibody to air-liquid interface (ALI) culture of PDO obtained from different cancer types, including MM, activates the PD-1-expressing CD3+ T cell compartment and induces cytotoxicity.